- $69.15m
- $60.65m
- $58.44m
LENSAR Q1 revenue falls 5%, hurt by merger uncertainty; recurring revenue rises 9%
Brief: Lensar Inc - Thomas R. Staab, Ii To Resign As CFO Effective May 8, 2026 - SEC Filing
Robotic cataract laser maker Lensar's Q4 revenue falls on system sales decline
Brief: LENSAR Q4 Net Income USD -1.5 Million
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
FTC monitoring how drug companies react to patent cliff, official says
Brief: US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon
Brief: Lensar® Announces Termination Of Merger Agreement With Alcon Research, Llc
NASDAQ RESUMED AT 05:00 PM
Brief: Alcon And Lensar Agree To Terminate Merger Agreement
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:25 PM
Brief: Lensar® Provides Update On Pending Acquisition By Alcon
LENSAR Q3 net loss widens
Brief: LENSAR Q3 Net Income USD -3.7 Million
Brief: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Lensar Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Medtech LENSAR Q2 revenue rises 10% but misses analyst expectations
Lensar Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: Lensar Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)